Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Jan 2026 for Astria Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleAndrew Komjathy
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Andrew Komjathy: trading record in brief
This profile gathers the share dealings of Andrew Komjathy in Astria Therapeutics, Inc., where the filings describe the role as senior executive. In total, 2 filings cover trades dated from 19 November 2021 to 23 January 2026.
No open-market sale appears; the market trades are 1 purchase worth €589. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 23 January 2026: a transaction, in Astria Therapeutics, Inc. The most recent open-market purchase was published on 23 November 2021, 1,790 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew Komjathy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10 sharesCommon StockSEC:0000905148-26-000319:0
100 shares@ US$6.695100.0% of flowCommon StockSEC:0001104659-21-143035:0
Canonical exit: 17 Feb 2022 (T+90)
2 of 2 declarations
